A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

Clinical trial NCT06360640 · COMPLETED

Trial details

NCT number: NCT06360640
Sponsor: AdjuTec Pharma AS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-09-02
Primary completion: 2025-03-10
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.